SCOTTSDALE, Arizona — Atypical antipsychotics, though not typically considered drugs of abuse, are now being used to enhance the effects of other drugs or as a way to counter the adverse effects of ...

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify [email protected] if there are concerns ...

As mentioned in section 4, conventional and atypical antipsychotics show significant differences both in receptor binding profile and in pharmacokinetic characteristics; we have focused in particular ...

Schizophrenia medication falls under two main categories: older, first-generation, or "typical" antipsychotics and newer drugs for schizophrenia known as second-generation or "atypical" antipsychotics ...

Epstein R.A., Bobo W.V., Shelton R.C., Arbogast P.G., Morrow J.A., Cooper W.O. Increasing use of atypical antipsychotics and anticonvulsants during pregnancy ...

Antipsychotic (AP) medications are increasingly recognised for their association with a heightened risk of infections. Clozapine, an atypical AP reserved for treatment-resistant schizophrenia (TRS), ...

Intra-Cellular Therapies’ atypical antipsychotic medication Caplyta has been on a roll, delivering fast commercial growth and coming up triumphant in yet another late-stage trial. In a statistically ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. Cobenfy (xanomeline/trospium chloride; formerly KarXT) was ...

Please provide your email address to receive an email when new articles are posted on . “We conducted this study because psychiatric disorders are common among women of reproductive age and while ...

Schizophrenia drug Cobenfy, a key component in Bristol Myers Squibb’s plan to navigate a transition period of major loss of exclusivity, has hit a phase 3 setback. Cobenfy as an adjunctive treatment ...